PURPOSE: Use of tissue-engineered vascular grafts (TEVGs) in the repair of congenital heart defects provides growth and remodeling potential. Little is known about the mechanisms involved in neovessel formation. We sought to define the role of seeded monocytes derived from bone marrow mononuclear cells (BM-MNCs) on neovessel formation. METHODS: Small diameter biodegradable tubular scaffolds were constructed. Scaffolds were seeded with the entire population of BM-MNC (n = 15), BM-MNC excluding monocytes (n = 15), or only monocytes (n = 15) and implanted as infrarenal inferior vena cava (IVC) interposition grafts into severe combined immunodeficiency/bg mice. Grafts were evaluated at 1 week, 10 weeks, or 6 months via ultrasonography and microcomputed tomography, as well as by histologic and immunohistochemical techniques. RESULTS: All grafts remained patent without stenosis or aneurysm formation. Neovessels contained a luminal endothelial lining surrounded by concentric smooth muscle cell layer and collagen similar to that seen in the native mouse IVC. Graft diameters differed significantly between those scaffolds seeded with only monocytes (1.022 +/- 0.155 mm) and those seeded without monocytes (0.771 +/- 0.121 mm; P = .021) at 6 months. CONCLUSIONS: Monocytes may play a role in maintaining graft patency. Incorporation of such findings into the development of second-generation TEVGs will promote graft patency and success. Copyright 2010 Elsevier Inc. All rights reserved.
PURPOSE: Use of tissue-engineered vascular grafts (TEVGs) in the repair of congenital heart defects provides growth and remodeling potential. Little is known about the mechanisms involved in neovessel formation. We sought to define the role of seeded monocytes derived from bone marrow mononuclear cells (BM-MNCs) on neovessel formation. METHODS: Small diameter biodegradable tubular scaffolds were constructed. Scaffolds were seeded with the entire population of BM-MNC (n = 15), BM-MNC excluding monocytes (n = 15), or only monocytes (n = 15) and implanted as infrarenal inferior vena cava (IVC) interposition grafts into severe combined immunodeficiency/bg mice. Grafts were evaluated at 1 week, 10 weeks, or 6 months via ultrasonography and microcomputed tomography, as well as by histologic and immunohistochemical techniques. RESULTS: All grafts remained patent without stenosis or aneurysm formation. Neovessels contained a luminal endothelial lining surrounded by concentric smooth muscle cell layer and collagen similar to that seen in the native mouse IVC. Graft diameters differed significantly between those scaffolds seeded with only monocytes (1.022 +/- 0.155 mm) and those seeded without monocytes (0.771 +/- 0.121 mm; P = .021) at 6 months. CONCLUSIONS: Monocytes may play a role in maintaining graft patency. Incorporation of such findings into the development of second-generation TEVGs will promote graft patency and success. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Tamar L Mirensky; Gregory N Nelson; Matthew P Brennan; Jason D Roh; Narutoshi Hibino; Tai Yi; Toshiharu Shinoka; Christopher K Breuer Journal: J Pediatr Surg Date: 2009-06 Impact factor: 2.545
Authors: Amit Goyal; Yinong Wang; Haili Su; Lawrence W Dobrucki; Matthew Brennan; Peter Fong; Alan Dardik; George Tellides; Albert Sinusas; Jordan S Pober; W Mark Saltzman; Christopher K Breuer Journal: J Pediatr Surg Date: 2006-04 Impact factor: 2.545
Authors: R Salcedo; M L Ponce; H A Young; K Wasserman; J M Ward; H K Kleinman; J J Oppenheim; W J Murphy Journal: Blood Date: 2000-07-01 Impact factor: 22.113
Authors: Jason D Roh; Gregory N Nelson; Matthew P Brennan; Tamar L Mirensky; Tai Yi; Tyrone F Hazlett; George Tellides; Albert J Sinusas; Jordan S Pober; W M Saltzman; Themis R Kyriakides; Christopher K Breuer Journal: Biomaterials Date: 2007-12-27 Impact factor: 12.479
Authors: Matthew P Brennan; Alan Dardik; Narutoshi Hibino; Jason D Roh; Gregory N Nelson; Xenophon Papademitris; Toshiharu Shinoka; Christopher K Breuer Journal: Ann Surg Date: 2008-09 Impact factor: 12.969
Authors: G N Nelson; J D Roh; T L Mirensky; Y Wang; T Yi; G Tellides; J S Pober; P Shkarin; E M Shapiro; W M Saltzman; X Papademetris; T M Fahmy; C K Breuer Journal: FASEB J Date: 2008-08-18 Impact factor: 5.191
Authors: Joseph T Patterson; Thomas Gilliland; Mark W Maxfield; Spencer Church; Yuji Naito; Toshiharu Shinoka; Christopher K Breuer Journal: Regen Med Date: 2012-05 Impact factor: 3.806
Authors: Ekene Onwuka; Cameron Best; Andrew Sawyer; Tai Yi; Eric Heuer; Malik Sams; Matthew Wiet; Hong Zheng; Themis Kyriakides; Christopher Breuer Journal: Regen Med Date: 2017-05-19 Impact factor: 3.806
Authors: Mitchel R Stacy; Cameron A Best; Mark W Maxfield; Maolin Qiu; Yuji Naito; Hirotsugu Kurobe; Nathan Mahler; Kevin A Rocco; Albert J Sinusas; Toshiharu Shinoka; Smita Sampath; Christopher K Breuer Journal: Tissue Eng Part C Methods Date: 2018-07-31 Impact factor: 3.056
Authors: Robert A Allen; Wei Wu; Mingyi Yao; Debaditya Dutta; Xinjie Duan; Timothy N Bachman; Hunter C Champion; Donna B Stolz; Anne M Robertson; Kang Kim; Jeffrey S Isenberg; Yadong Wang Journal: Biomaterials Date: 2013-10-09 Impact factor: 12.479
Authors: Natalie Luanne Leong; Nima Kabir; Armin Arshi; Azadeh Nazemi; Ben Wu; Frank A Petrigliano; David R McAllister Journal: Tissue Eng Part A Date: 2015-04-07 Impact factor: 3.845
Authors: Narutoshi Hibino; Tai Yi; Daniel R Duncan; Animesh Rathore; Ethan Dean; Yuji Naito; Alan Dardik; Themis Kyriakides; Joseph Madri; Jordan S Pober; Toshiharu Shinoka; Christopher K Breuer Journal: FASEB J Date: 2011-08-24 Impact factor: 5.191
Authors: Jeffrey T Krawiec; Justin S Weinbaum; Claudette M St Croix; Julie A Phillippi; Simon C Watkins; J Peter Rubin; David A Vorp Journal: Tissue Eng Part A Date: 2014-09-16 Impact factor: 3.845